Table 2.
Operative data for patients submitted to isolated Roux loop pancreaticojejunostomy (IRPJ) or pancreaticogastrostomy (PG)
| Variable | All patients | IRPJ group | PG group | P-value |
|---|---|---|---|---|
| (n = 90) | (n = 45) | (n = 45) | ||
| Cirrhotic liver, n (%) | 12 (13.3%) | 7 | 5 | 0.535 |
| Size of mass, cm, median (range) | 2 (0.5–6.0) | 2 (0.5–6.0 cm) | 3 (1.0–4.0) | 0.477 |
| <2 cm, n (%) | 46 (51.5%) | 26 | 20 | 0.206 |
| >2 cm, n (%) | 44 (48.5%) | 19 | 25 | |
| Ampullary site, n (%) | 36 (40.0%) | 19 | 17 | |
| Pancreatic head mass | 46 (51.1%) | 20 | 26 | 0.313 |
| Duodenal tumour | 6 (6.7%) | 4 | 2 | |
| Lower CBD tumour | 2 (2.2%) | 2 | 0 | |
| Indication for resection, n (%) | ||||
| Malignant | 75 (83.4%) | 38 | 37 | 0.466 |
| Benign | 13 (14.4%) | 6 | 7 | |
| Borderline | 2 (2.2%) | 1 | 1 | |
| Pancreatic duct diameter, mm, median (range) | 3.5 (1–12) | 3 (1–12) | 4 (2–10) | 0.632 |
| <3 mm, n (%) | 43 (47.8%) | 21 | 22 | 0.833 |
| >3 mm, n (%) | 47 (52.2%) | 24 | 23 | |
| Pancreatic duct to posterior border, mm, median (range) | 3 (1–15) | 3 (1–15) | 3 (1–15) | 0.537 |
| <3 mm, n (%) | 46 (51.1%) | 23 | 23 | 1 |
| >3 mm, n (%) | 44 (48.9%) | 22 | 22 | |
| Pancreatic consistency, n (%) | ||||
| Firm | 42 (46.7%) | 23 | 19 | 0.398 |
| Soft | 48 (53.3%) | 22 | 26 | |
| Pancreatic remnant mobilization, cm, median (range) | 2 (1–3) | 2 (1–2) | 2 (1–3) | 0.039 |
| Total operative time, min, median (range) | 300 (210–480) | 320 (240–480) | 300 (210–420) | 0.047 |
| Operative time for reconstruction, min, median (range) | 110 (90–125) | 115 (95–125) | 100 (90–120) | <0.001 |
| Blood loss, ml, median (range) | 500 (50–3000) | 500 (50–2500) | 400 (100–3000) | 0.732 |
CBD, common bile duct.